Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04773639 · ClinicalTrials.gov registry record · NA

Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention

A NA study of Metastatic Cancer and Depression, Anxiety, sponsored by University of Colorado, Boulder.

Completed
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT04773639: Completed NA study of Metastatic Cancer and Depression, Anxiety, sponsored by University of Colorado, Boulder.

NCT04773639 is a NA study of Metastatic Cancer and Depression, Anxiety that has completed, run by University of Colorado, Boulder. The registered enrollment target is 240 participants, below the 442-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04773639, a NA study of Metastatic Cancer and Depression, Anxiety, has completed, sponsored by University of Colorado, Boulder.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Adults diagnosed with metastatic cancer commonly experience depression and anxiety symptoms, which can interfere with advance care planning. This randomized clinical trial evaluates a novel, piloted, primary palliative care intervention that addresses advance care planning and psychosocial needs of patients with metastatic cancer. The intervention focuses on patients with elevated anxiety and depression (anx/dep) symptoms-those with highest psychosocial needs who may be at greatest risk for advance care planning non-completion. The intervention is founded on an evidence-based intervention approach known as Acceptance and Commitment Therapy (ACT) that reduces distress and promotes behavior change through theory-driven mechanisms. In the proposed randomized trial, M-ACT will be compared to a usual care control condition. The study will also assess the association between advance care planning and anx/dep symptoms, thereby informing the critical practice question of whether anx/dep symptoms should be addressed concurrently with advance care planning. The study will enroll patients with Stage IV solid tumor cancer (N=240) within Rocky Mountain Cancer Centers, randomized 1:1 to M-ACT or usual care. The study aims to: 1) Evaluate the hypothesis that M-ACT will increase advance care planning completion (primary outcome) and sense of life meaning, and reduce anx/dep symptoms and fear of dying relative to usual care control. 2) Assess the association between anx/dep symptoms and advance care planning at baseline and over time, testing the hypothesis that decreases in anx/dep symptoms at post- intervention will be associated with increases in advance care planning at follow-up. 3) Assess M-ACT's hypothesized mechanisms to specify how the intervention works (exploratory aim). Given their advance care planning and psychosocial needs, and poor access to palliative care, rigorously investigating M-ACT has the potential to benefit community patients with metastatic cancer and to a

Primary Outcome

The primary outcome is defined as change in the number of steps taken toward ACP completion from baseline through 2-month follow-up. ACP steps will be assessed with a checklist adapted from the M-ACT pilot study by consulting the Hospice \& Palliative Nurses Association online ACP resources and the study team, and refined by soliciting pilot participants' feedback on item clarity. The checklist describes each ACP step and asks patients to indicate steps taken to date.

Interventions

  • BEHAVIORAL Multi-Modal Palliative Care Intervention
  • BEHAVIORAL Usual Care Control Condition

Study Locations (1)

Colorado

  • Rocky Mountain Cancer Centers - Boulder

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2021-01-11
Est. Completion 2025-01-31
Phase NA
University of Colorado, Boulder

69 total trials

What the finished NCT04773639 record still lists

NCT04773639 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 442-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (46% lower).

The record links to 2 conditions, with Metastatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which Multi-Modal Palliative Care Intervention is the first listed.

NCT04773639 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT04773639 about?

NCT04773639 is a clinical study titled "Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention". Adults diagnosed with metastatic cancer commonly experience depression and anxiety symptoms, which can interfere with advance care planning. This randomized clinical trial evaluates a novel, piloted, primary palliative care intervention that addresses advance care planning and psychosocial needs of ...

What is the current status of trial NCT04773639?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2021-01-11. Estimated completion is 2025-01-31.

What conditions does trial NCT04773639 study?

This clinical trial studies the following conditions: Metastatic Cancer, Depression, Anxiety.

What interventions are being tested in trial NCT04773639?

The interventions under investigation include: Multi-Modal Palliative Care Intervention (BEHAVIORAL), Usual Care Control Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT04773639?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04773639 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metastatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04773639's enrollment target sits among peer trials

240 21st of 109 higher than 89 of 109 other Metastatic Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metastatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04773639, the US trial registry maintained by the National Library of Medicine. NCT04773639 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.